venetoclax
New Biomarker Predicts MDS Treatment Response
Researchers have identified a new biomarker to predict treatment response for myelodysplastic syndromes (MDS), ...
MARCH 22, 2022
Venclexta Approved for Treatment of Previously Untreated CLL/SLL
The FDA approved venetoclax (Venclexta, AbbVie/Genentech) for the treatment of adults with chronic lymphocytic ...
JUNE 5, 2019
FDA Halts MM Trial, Deaths Seen in Venclexta Arm
The FDA halted a clinical trial of Venclexta for MM because of an increased risk for death; does not affect ...
MARCH 22, 2019
Venclexta Approved for CLL/SLL After 1 Prior Therapy
The FDA granted regular approval to venetoclax in patients with chronic lymphocytic leukemia (CLL) or small ...
JUNE 18, 2018
Load more